VP noticeably inhibited the expression levels of YAP/TAZ target genes and VEGF-associated molecular reactions, suggesting that the vasoconstrictor activity of VP in human skin vessels is able to modulate erythema and telangiectasia in rosacea (Figure 3). The gene discussed is VEGFA; the disease is Telangiectasia.